Skip to Main Content

Paper Details

Superimmunity by pan-sarbecovirus nanobodies.
Cell Rep
13
2022
PiN-31, SARS, SARS-, SARS-CoV, SARS-CoV-2, SARS-CoV-2 antibodies, SARS-CoV-2 spike, camelid, psNb, psNbs, receptor binding sites
Author NameAffiliation
Dina Schneidman-DuhovnyThe Hebrew University of Jerusalem
Dina Schneidman-DuhovnyThe Hebrew University of Jerusalem
Ian A WilsonUSA Skaggs Institute for Chemical Biology
Derek J TaylorCase Western Reserve University
Yi ShiUniversity of Pittsburgh, USA The University of Pittsburgh and Carnegie Mellon University Program for Computational Biology, USA Department of Pharmacological Sciences, Icahn School of Medicine at Mount Sinai
  • 1 - 5

Datasets

Release 1.2